Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Quick Stats
Jan 30, 202658.0
AI Score
HOLD0.72
Volume Ratio
Mar 04, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
ZYME Stock Summary
Last updated Jan 30, 2026
ZYME is currently trading at $22.53, positioned above its 200-day moving average of $17.08, indicating a long-term uptrend. The stock has a 52-week range of $9.03 to $28.49.
Technical Analysis: The 50-day moving average stands at $24.99, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.291, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.031, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ZYME at 58.0/100 with a HOLD recommendation.
ZYME (Zymeworks Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 39.291 |
| CMF (20) | -0.031 |
| ROC (10) | -4.655 |
| ADX (14) | 25.967 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.594 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -81.071 |
| MFI (14) | 43.166 |
ZYME Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ZYME Price vs Max Options Open Interest
ZYME Max Change In Options Open Interest
ZYME Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ZYME Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ZYME Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ZYME Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Zymeworks Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ZYME Moving Averages Analysis
Zymeworks Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
ZYME (Zymeworks Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 23.13 |
| 20 | 23.7 |
| 30 | 24.69 |
| 50 | 24.99 |
| 100 | 21.28 |
| 200 | 17.08 |
ZYME Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 billion |
| Earnings/Share ($) | -0.85 |
| Net Proft Margin (%) | -0.4716 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.873 |
| EPS Estimate Next Year ($) | 0.3266 |
| WallStreet Target Price ($) | 35.6154 |
| Most Recent Quarter |